Access Cardiosystems, Inc. v. Fincke (In Re Access Cardiosystems, Inc.)

438 B.R. 16, 2010 Bankr. LEXIS 3647, 53 Bankr. Ct. Dec. (CRR) 245, 2010 WL 4053614
CourtUnited States Bankruptcy Court, D. Massachusetts
DecidedOctober 14, 2010
Docket19-10440
StatusPublished
Cited by5 cases

This text of 438 B.R. 16 (Access Cardiosystems, Inc. v. Fincke (In Re Access Cardiosystems, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Access Cardiosystems, Inc. v. Fincke (In Re Access Cardiosystems, Inc.), 438 B.R. 16, 2010 Bankr. LEXIS 3647, 53 Bankr. Ct. Dec. (CRR) 245, 2010 WL 4053614 (Mass. 2010).

Opinion

MEMORANDUM OF DECISION

HENRY J. BOROFF, Bankruptcy Judge.

Before the Court is a motion for summary judgment (the “Summary Judgment Motion”) filed by Access Cardiosystems, Inc. (“Access”), four of its individual investors (the “Investors”), and the corporate entities through which several of those investments were made (together, the “Plaintiffs”). 2 Through their motion, the Plaintiffs seek an award of damages based on this Court’s previous findings and rulings on liability with regard to their claims against Randall Fincke, former Access shareholder, officer, and director. See Access Cardiosystems, Inc. v. Fincke (In re Access Cardiosystems, Inc.), 404 B.R. 593 (Bankr.D.Mass.2009). The issue now presented is whether, in light of the Court’s ruling that Fincke violated Massachusetts General Laws ch. 110A, § 410(a)(2) (“§ 410(a)(2)”) 3 , the Investors are entitled to rescind their investment transactions as a matter of law.

I. FACTS AND TRAVEL OF THE CASE 4

Access Cardiosystems, Inc., was formed in 2000 by Randall Fincke (with the assis *19 tance of others) to develop, market, and sell a portable automated external defibrillator (the “Access AED”). From 2001 through the date of confirmation of its Chapter 11 plan, 5 Access’s operations, including as debtor-in-possession in the underlying bankruptcy case, were substantially funded by its individual Investors through various loans and stock purchases. 6

In April 2003, as a result of the conversion of much of the Investors’ debt to equity and their purchase of additional Access stock, Fincke ceded his majority ownership of Access to the Investors (the “April 2003 Transaction”). Coincident with the April 2003 Transaction, a formal Board of Directors was established, comprised of Radley, Moriarty, Zimmel, and Fincke. Over the course of the ensuing months, tension and suspicions regarding Fincke’s perceived misrepresentations and mismanagement of Access grew, and in November 2003, the Board voted to relieve Fincke of his executive and managerial positions. Fincke ultimately rejected the Board’s offer to position him as Access’s Chief Technology Officer and non-executive Chairman of the Board, and he left the company in January 2004. Shortly thereafter, Access exercised its rights under its stockholder agreement with Fincke, repurchasing all of Fincke’s shares in Access for $1.00.

Disputes between the Plaintiffs and Fincke did not end there, however. In response to Fincke’s assertion some months later that he owned the intellectual property related to the Access AED (the “Intellectual Property”), the Plaintiffs filed suit against Fincke in the Massachusetts Superior Court. In the Superior Court action, the Plaintiffs sought a declaratory judgment that Access, and not Fincke, owned the Intellectual Property and also asserted several claims against Fincke for his alleged breach of fiduciary duties, fraud, negligent misrepresentation, and securities fraud. Fincke counterclaimed, seeking declaratory determinations that he owned the Intellectual Property and that the purported repurchase of his Access stock was invalid. Fincke also sought damages on various breach of fiduciary duty, breach of contract, promissory estop-pel, and wrongful discharge theories.

While that suit was pending, the struggling company suffered its final blow — the recall of substantially all of the Access AEDs. And, on February 8, 2005, Access filed for protection under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code” or the “Code”), 11 U.S.C. § 101 et seq. Fincke subsequently removed the pending Superior Court action to this Court. See Fed. R. Bankr.P. 9027.

On March 31, 2006, this Court issued a memorandum of opinion and partial judg *20 ment on the parties’ cross-motions for summary judgment. See Access I, 340 B.R. 127. That judgment disposed of the contested ownership of the Intellectual Property. The Court ruled that Access, and not Fincke, rightfully owned the Intellectual Property, and Fincke was ordered to assign any rights he held in the Intellectual Property to Access. Id.

Following the partial summary judgment ruling, the parties agreed to bifurcate the remaining claims — trying issues of liability first and then, to the extent necessary, trying issues related to damages. A lengthy trial on liability ensued, and on April 17, 2009, the Court issued a memorandum of opinion and partial judgment on the parties’ remaining claims. See Access II, 404 B.R. 593. At the conclusion of trial, the Court found and ruled for the Investors and Access with regard to each of the Counterclaims. Id. at 699. The Court also ruled that Fincke had breached his fiduciary duties to Access in two respects: (1) by receiving reimbursements for personal expenses charged to his company credit cards, id. at 694, and (2) “by causing the company to repay its [debts to] him at a time when Access was desperately in need of cash and without disclosure to and the consent of disinterested shareholders or the Board.” Id. at 699. As to the remainder of the Plaintiffs’ claims, the Court found and ruled for Fincke on each, “with the exception of its findings and rulings that Fincke [wa]s liable ... for fraud, negligent misrepresentation, and violation of § 410(a)(2) on account of the false statement in the Business Plan [dated October 2002] that Access was advised by its patent counsel that its product did not infringe any patents known to him....” Id. at 698-99.

The Investors have now filed their Summary Judgment Motion on the issue of damages, to which Fincke objects. The issue to be decided is fairly narrow. The Plaintiffs have waived any claims for damages arising from Access’s repayment of personal expenses charged on Fincke’s credit cards. Hr’g Tr. 14:18-19, June 3, 2010. And Fincke has waived any objection to the entry of judgment for Access in the amount of $281,534.62 for Fincke’s causing Access to repay his personal loans to the company in violation of his fiduciary duties. Hr’g Tr. 14:4-12. The sole remaining issue is whether the Investors are entitled to rescind all of their investment transactions and recover the total of their investments in Access on account of Fincke’s violation of § 410(a)(2). 7

II. POSITIONS OF THE PARTIES

A. The Investors

The Investors assert that the calculation of damages is simple, straightforward, and capable of summary determination.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
438 B.R. 16, 2010 Bankr. LEXIS 3647, 53 Bankr. Ct. Dec. (CRR) 245, 2010 WL 4053614, Counsel Stack Legal Research, https://law.counselstack.com/opinion/access-cardiosystems-inc-v-fincke-in-re-access-cardiosystems-inc-mab-2010.